ClinicalTrials.Veeva

Menu

Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden (ECOPASEP)

L

Lille Catholic University

Status

Completed

Conditions

Economic Burden
Quality of Life
Social Interaction
Multiple Sclerosis
Capability
Physical Disability

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02592265
RC-P0018

Details and patient eligibility

About

The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.

Full description

The goal of this study is to evaluate prospectively the economic burden of Multiple Sclerosis (MS) in France by calculating direct costs (medical and non-medical) and indirect costs and by estimating consequences of MS on utility (QALY) of patients and caregivers in a societal perspective.

Enrollment

233 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant aged 18 or more
  • Confirmed MS diagnosis (McDonald 2005)
  • Defined type of MS according classification of Lublin and Reingold

Exclusion criteria

  • Subject living in an institution
  • Severe cognitive dysfunction preventing to answer questionnaire
  • Subject already included in other clinical study (phase 1 to 3)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems